Multifocal motor neuropathy
| Multifocal motor neuropathy | |
|---|---|
| Synonyms | MMN |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Muscle weakness, muscle atrophy, cramps, fasciculations |
| Complications | N/A |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Autoimmune disease |
| Risks | Genetic predisposition, environmental factors |
| Diagnosis | Electromyography, nerve conduction study, anti-GM1 antibody test |
| Differential diagnosis | Amyotrophic lateral sclerosis, chronic inflammatory demyelinating polyneuropathy, multifocal acquired demyelinating sensory and motor neuropathy |
| Prevention | N/A |
| Treatment | Intravenous immunoglobulin, immunosuppressive drugs |
| Medication | N/A |
| Prognosis | Generally good with treatment |
| Frequency | Rare |
| Deaths | N/A |
Multifocal Motor Neuropathy (MMN) is a rare neuromuscular disease characterized by progressive, asymmetric muscle weakness and atrophy. The disease is believed to be caused by autoimmune responses leading to damage of peripheral nerves.
Symptoms[edit]
The primary symptoms of MMN are weakness and muscle atrophy, often accompanied by fasciculations and mild sensory changes. The disease typically begins in the hands and gradually progresses to other parts of the body.
Causes[edit]
The exact cause of MMN is unknown, but it is believed to be an autoimmune disease. In this case, the body's immune system mistakenly attacks the peripheral nerves, leading to their damage and the subsequent symptoms.
Diagnosis[edit]
Diagnosis of MMN is based on clinical symptoms, electromyography (EMG) findings, and the presence of anti-GM1 antibodies in the blood. However, not all patients with MMN have these antibodies, making diagnosis challenging.
Treatment[edit]
Treatment for MMN typically involves immunoglobulin therapy, which can help to reduce symptoms and slow the progression of the disease. Other treatments, such as corticosteroids and plasma exchange, may also be used, but their effectiveness is less well established.
Prognosis[edit]
The prognosis for individuals with MMN varies. Some people may experience only mild symptoms and have a normal lifespan, while others may experience significant disability. However, MMN does not typically affect life expectancy.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
